Key result
Shiraz Heart Study protocol targets 10,000 Iranian adults to assess cardiovascular disease risk factors.
Why the study?
The significant increase in cardiovascular morbidity and mortality globally and lack of knowledge on underlying causes in Iran motivated this study.
Cohort (n=10,000)
This protocol outlines a prospective cohort study of 10,000 adults in Iran to identify predisposing elements for cardiovascular diseases.
INTRODUCTION: The significant increase in the rate of morbidity and mortality due to cardiovascular diseases has become a health challenge globally. Lack of enough knowledge on the underlying causes in Iran and taking the unique characteristics of the Shiraz metropolitan city (the capital city of Fars Province) into consideration prompted us to conduct the Shiraz Heart Study. The aim of this study is to determine the predisposing elements leading to coronary heart disease, cerebrovascular disease and peripheral arterial disease. METHODS AND ANALYSIS: In this population-based, prospective study, family physician clinics will become the executive arms. Participants aged 40-70 years old will be recruited to achieve a sample size of 10 000. Socioeconomicta and anthropometric indices supplemented by physical activity, nutritional and psychological questionnaires, as well as routine blood laboratory tests, medical history and electrocardiographic records, will be collected at enrolment in clinics. In addition, blood samples will be obtained to explore the possible role of genetics in outcome occurrence. Follow-up with blood sampling, completion of a lifestyle questionnaire and evaluation of clinical risk factors will be carried out five times in a 2-year interval for all participants. Advanced statistical methods such as mixed model and time-to-event models will be used for data analysis. ETHICS AND DISSEMINATION: This study is in accordance with the Helsinki Declaration and has been approved by the Research Ethics Committee of Shiraz University of Medical Sciences (No: 2017-358). Signing a written informed consent is the preliminary step. Participants are free to withdraw on their request at any time. Collected data are kept encrypted in a software with authorities' access only. Findings of the study will be published at a national or international scale through peer-reviewed journals.
No takes yet. Share an insight, caveat, or question.
Zibaeenezhad et al. (2019) conducted a cohort in Cardiovascular diseases (n=10,000). Cardiovascular risk factors was evaluated on Coronary heart disease, cerebrovascular disease and peripheral arterial disease. The Shiraz Heart Study is a prospective cohort protocol aiming to recruit 10,000 adults aged 40-70 years in Iran to evaluate risk factors for cardiovascular diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: